Cargando…

Region-Specific Effects of Immunotherapy With Antibodies Targeting α-synuclein in a Transgenic Model of Synucleinopathy

Synucleinopathies represent a group of neurodegenerative disorders which are characterized by intracellular accumulation of aggregated α-synuclein. α-synuclein misfolding and oligomer formation is considered a major pathogenic trigger in these disorders. Therefore, targeting α-synuclein species repr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kallab, Martin, Herrera-Vaquero, Marcos, Johannesson, Malin, Eriksson, Fredrik, Sigvardson, Jessica, Poewe, Werner, Wenning, Gregor K., Nordström, Eva, Stefanova, Nadia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039792/ https://www.ncbi.nlm.nih.gov/pubmed/30022929 http://dx.doi.org/10.3389/fnins.2018.00452

Ejemplares similares

Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2012)

Targeted overexpression of human α-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure
por: Stemberger, Sylvia, et al.
Publicado: (2010)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia
por: Fellner, Lisa, et al.
Publicado: (2013)

Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy
por: Sturm, Edith, et al.
Publicado: (2016)

High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
por: Heras-Garvin, Antonio, et al.
Publicado: (2020)

Signs of Chronic Hypoxia Suggest a Novel Pathophysiological Event in α‐Synucleinopathies
por: Heras‐Garvin, Antonio, et al.
Publicado: (2020)

Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy
por: Spencer, Brian, et al.
Publicado: (2017)

Low CSF Levels of Both α-Synuclein and the α-Synuclein Cleaving Enzyme Neurosin in Patients with Synucleinopathy
por: Wennström, Malin, et al.
Publicado: (2013)

Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: Experimental evidence
por: Kuzdas, Daniela, et al.
Publicado: (2013)

α-Synuclein Transgenic Drosophila As a Model of Parkinson's Disease and Related Synucleinopathies
por: Mizuno, Hideya, et al.
Publicado: (2010)

Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges
por: Ndayisaba, Alain, et al.
Publicado: (2019)

Toll-like receptor 4 stimulation with monophosphoryl lipid A ameliorates motor deficits and nigral neurodegeneration triggered by extraneuronal α-synucleinopathy
por: Venezia, Serena, et al.
Publicado: (2017)

Modulation of α-synuclein expression in transgenic animals for modelling synucleinopathies — is the juice worth the squeeze?
por: Buchman, Vladimir L., et al.
Publicado: (2008)

Histone Deacetylase 6 and the Disease Mechanisms of α-Synucleinopathies
por: Lemos, Miguel, et al.
Publicado: (2020)

Involvement of Peripheral Nerves in the Transgenic PLP-α-Syn Model of Multiple System Atrophy: Extending the Phenotype
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2015)

α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
por: Grossauer, Anna, et al.
Publicado: (2023)

The Role of Glia in Alpha-Synucleinopathies
por: Fellner, Lisa, et al.
Publicado: (2012)

Intact Olfaction in a Mouse Model of Multiple System Atrophy
por: Krismer, Florian, et al.
Publicado: (2013)

Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
por: Nimmo, Jacqui T., et al.
Publicado: (2020)

Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies
por: Outeiro, Tiago Fleming, et al.
Publicado: (2008)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
por: Gu, Hao, et al.
Publicado: (2021)

The Interplay between α-Synuclein and Microglia in α-Synucleinopathies
por: Deyell, Jacob S., et al.
Publicado: (2023)

A Combined α-Synuclein/Fibril (SynFib) Model of Parkinson-Like Synucleinopathy Targeting the Nigrostriatal Dopamine System
por: Björklund, Anders, et al.
Publicado: (2022)

The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies
por: Leys, Fabian, et al.
Publicado: (2021)

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies
por: Refolo, Violetta, et al.
Publicado: (2019)

Correction: Novel antibodies detect additional α-synuclein pathology in synucleinopathies: potential development for immunotherapy
por: Nimmo, Jacqui T., et al.
Publicado: (2023)

Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived α-synuclein in oligodendroglia: implications for MSA pathogenesis
por: Fellner, Lisa, et al.
Publicado: (2018)

Transmission of Synucleinopathies in the Enteric Nervous System of A53T Alpha-Synuclein Transgenic Mice
por: Lee, He-Jin, et al.
Publicado: (2011)

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
por: Okuzumi, Ayami, et al.
Publicado: (2023)

α-Synuclein oligomers and fibrils: partners in crime in synucleinopathies
por: Bigi, Alessandra, et al.
Publicado: (2023)

Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy
por: Badiola, Nahuai, et al.
Publicado: (2011)

α-Synuclein filaments from transgenic mouse and human synucleinopathy-containing brains are major seed-competent species
por: Morgan, Sophie A., et al.
Publicado: (2020)

Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2015)

Investigating the neuroprotective effect of AAV-mediated β-synuclein overexpression in a transgenic model of synucleinopathy
por: Sargent, Dorian, et al.
Publicado: (2018)

Immunotherapies in Huntington's disease and α-Synucleinopathies
por: Fatoba, Oluwaseun, et al.
Publicado: (2020)

Triggering of Inflammasome by Aggregated α–Synuclein, an Inflammatory Response in Synucleinopathies
por: Codolo, Gaia, et al.
Publicado: (2013)

Enteric nervous system α-synuclein immunoreactivity in idiopathic REM sleep behavior disorder
por: Sprenger, Fabienne S., et al.
Publicado: (2015)

α-Synuclein interacts directly but reversibly with psychosine: implications for α-synucleinopathies
por: Abdelkarim, Hazem, et al.
Publicado: (2018)

Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
por: Kawahata, Ichiro, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_854j0mkl73lolak64gp6tvf6ok